HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+13.28%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$168M
AUM Growth
+$168M
(-3.8%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
40.66%
Holding
139
New
26
Increased
28
Reduced
31
Closed
34
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$2.95M |
| 2 |
SJI
South Jersey Industries, Inc.
SJI
|
$2.82M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$1.79M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$1.37M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$1.26M |
Top Sells
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$4.46M |
| 2 |
Cytokinetics
CYTK
|
$3.54M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
$3.26M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.17M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$2.81M |
Sector Composition
| 1 | Healthcare | 46.64% |
| 2 | Technology | 19.92% |
| 3 | Financials | 17.76% |
| 4 | Consumer Discretionary | 3.48% |
| 5 | Communication Services | 2.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
NovoCure
NVCR
$1.38B
| $2.05M | 1.22% | 28,007 | – | – |
|
27
Kura Oncology
KURA
$686M
| $2.04M | 1.21% | 164,113 -33,963 | -17% | -$421K |
|
28
Apellis Pharmaceuticals
APLS
$3.48B
| $2.02M | 1.2% | 39,111 -14,431 | -27% | -$746K |
|
|
CPARU
29
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $2.01M | 1.19% | 200,000 | – | – |
|
|
VRNA
30
Verona Pharma
VRNA
$9.16B
| $1.79M | 1.07% | +68,691 | New | +$1.79M |
|
31
Crinetics Pharmaceuticals
CRNX
$2.92B
| $1.72M | 1.02% | 93,893 +1,846 | +2% | +$33.8K |
|
32
Edgewise Therapeutics
EWTX
$1.51B
| $1.68M | 1% | 187,480 +84,018 | +81% | +$751K |
|
33
Arcus Biosciences
RCUS
$1.13B
| $1.48M | 0.88% | 71,650 | – | – |
|
|
KDNY
34
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.3M | 0.77% | 49,495 -34,056 | -41% | -$892K |
|
35
Biomea Fusion
BMEA
$116M
| $1.22M | 0.72% | 144,727 | – | – |
|
|
DICE
36
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.22M | 0.72% | +39,064 | New | +$1.22M |
|
37
Dyne Therapeutics
DYN
$1.92B
| $1.19M | 0.7% | 102,431 | – | – |
|
38
Celldex Therapeutics
CLDX
$1.47B
| $1.1M | 0.65% | 24,742 -684 | -3% | -$30.5K |
|
39
Ventyx Biosciences
VTYX
$171M
| $1.09M | 0.65% | +33,256 | New | +$1.09M |
|
40
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $1.05M | 0.62% | 42,396 | – | – |
|
41
Rhythm Pharmaceuticals
RYTM
$6.85B
| $1.03M | 0.61% | +35,478 | New | +$1.03M |
|
42
Akero Therapeutics
AKRO
$3.74B
| $1.02M | 0.61% | +18,629 | New | +$1.02M |
|
43
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1M | 0.6% | 9,701 -120 | -1% | -$12.4K |
|
44
Sarepta Therapeutics
SRPT
$1.78B
| $999K | 0.59% | 7,713 -296 | -4% | -$38.4K |
|
45
Xenon Pharmaceuticals
XENE
$2.98B
| $999K | 0.59% | 25,340 +2,768 | +12% | +$109K |
|
46
Alnylam Pharmaceuticals
ALNY
$58.5B
| $964K | 0.57% | 4,056 -183 | -4% | -$43.5K |
|
47
Amicus Therapeutics
FOLD
$2.34B
| $944K | 0.56% | 77,314 +8,484 | +12% | +$104K |
|
48
Vaxcyte
PCVX
$4B
| $940K | 0.56% | 19,606 -1,264 | -6% | -$60.6K |
|
49
Galapagos
GLPG
$2.07B
| $919K | 0.55% | 20,701 +3,202 | +18% | +$142K |
|
|
SWTX
50
DELISTED
SpringWorks Therapeutics
SWTX
| $905K | 0.54% | 34,803 +21,915 | +170% | +$570K |
|